Fig. 2
From: COVID-19 associated Mucormycosis among ICU patients: risk factors, control, and challenges
Risk factors enhancing COVID-19 associated mucormycosis. Many risk factors enhancing ICU COVID-19 associated mucormycosis as hospitalization and length of stay in ICU, contaminated oxygen mask and other ICU devices, taking strong antibiotics, steroids and immunosuppressives, destruction of ciliated cell in nose and lung damage, increase circulating free iron concentration, dysregulation in immune cells, impaired phagocytosis and viral mutation and appear of new variants